Lululemon Athletica Stock Surges – Is the Momentum Sustainable?

Lululemon Athletica shares rose 7.8% this morning to a price of $321.17. The stock is still trading within range of its average target price of $314.99, and over the last 52 weeks, it has recorded a -21.3% performance. Analysts have given the Large-Cap Apparel Manufacturing stock target prices ranging from $194.0 to $445.0 dollars per share, with an average rating of buy.

Lululemon Athletica has an average level of shares sold short, at 5.7% of its total share float. The stock's short ratio (also called days to cover) is 2.85. The company's insiders own 4.63% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Institutional investors own 94.8% of Lululemon Athletica's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Lululemon Athletica

Date Reported Holder Percentage Shares Value
2024-06-30 FMR, LLC 15% 17,901,815 $5,749,526,163
2024-06-30 Vanguard Group Inc 10% 11,742,011 $3,771,181,830
2024-06-30 Blackrock Inc. 8% 9,139,415 $2,935,306,038
2024-06-30 State Street Corporation 4% 4,834,051 $1,552,552,224
2024-06-30 Edgewood Management Llc 3% 3,232,743 $1,038,260,112
2024-06-30 Alliancebernstein L.P. 2% 2,646,098 $849,847,330
2024-06-30 Geode Capital Management, LLC 2% 2,430,534 $780,614,637
2024-06-30 Morgan Stanley 2% 2,064,888 $663,180,106
2024-06-30 Arrowstreet Capital, Limited Partnership 2% 1,813,051 $582,297,614
2024-06-30 American Century Companies Inc 2% 1,769,096 $568,180,586
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS